Company profile
Future Fertility
AI-powered oocyte assessment for personalized fertility treatment decisions.
- Category
- Healthcare AI
- Headquarters
- Toronto, Ontario
- Sells to
- Mid-market
- Business model
- Not stated
- Deployment
- Cloud / SaaS
- Pricing
- Not published
- Builds own models
- Yes
- Modalities
- Image
What Future Fertility does
Future Fertility delivers objective, non-invasive insight into egg (oocyte) quality using clinically validated AI tools. These tools support earlier, more informed decision-making in IVF, egg freezing, and donor programs. Developed in partnership with fertility clinics and embryology labs globally, their solutions improve counselling, cycle planning, and transparency, integrating seamlessly into existing lab workflows. They also provide personalized reports for patients to understand their unique egg quality.
Products
- ROSE™A purpose-built tool for donor egg populations, leveraging Future Fertility's clinically validated AI model to improve oocyte distribution using objective quality insights.
- VIOLET™A personalized report providing clear egg quality insights to help patients make more informed decisions along the fertility journey. It offers objective data regarding the chance of success for each frozen egg.
- MAGENTA™A personalized report providing clear egg quality insights to help patients make more informed decisions along the fertility journey.
- MyFutureFertility™A patient insights platform that provides secure access to personalized egg quality reports directly to patients' phones, along with helpful patient education resources.
Key capabilities
- Objective, non-invasive oocyte quality assessment
- Leverages the industry's largest & most diverse image dataset
- Powered by advanced artificial intelligence
- Clinically validated AI models
- Seamless integration into existing lab workflows
- Personalized egg quality reports
- Patient education resources
- Secure access to reports via MyFutureFertility™ platform
Use cases
- Improve patient counselling with objective oocyte quality insights
- Support earlier, more informed decision-making in IVF
- Support earlier, more informed decision-making in egg freezing
- Support earlier, more informed decision-making in donor programs
- Optimize oocyte distribution based on objective oocyte quality data
- Understand unique egg quality with personalized reports
- Improve treatment planning
- Provide greater clarity to patients regarding their reproductive potential
- Manage patient expectations
- Tailor treatment plans
- Standardization across clinics for oocyte quality assessment
AI approach
Future Fertility uses advanced artificial intelligence to deliver objective and reliable methodology to evaluate oocyte quality. Their non-invasive tools leverage the industry's largest and most diverse image dataset. They develop clinically validated AI tools that integrate seamlessly into existing lab workflows. Their AI models have been validated in partnership with leading fertility clinics and findings published in peer-reviewed journals. They specifically mention visual machine-learning and computer vision.
Tech named: artificial intelligence, AI, visual machine-learning, computer vision, machine learning
Industries served
- Hospitals and Health Care
- Reproductive Health
- Fertility Clinics
- Embryology Labs
- Egg Banks
What it says sets it apart
- First tool to use artificial intelligence to score egg quality (in 2018)
- Proprietary AI models developed with medical and mathematics expertise
- Clinically validated tools backed by science and published in peer-reviewed journals
- Leverages the industry's largest & most diverse image dataset
- Focus on objective, non-invasive insight into egg (oocyte) quality
- Seamless integration into existing lab workflows
- Personalized patient insights and education through MyFutureFertility™
Funding rounds we track
M Ventures, Whitecap Venture Partners, Sandpiper Ventures, Gaingels, Jolt VC
From the AI funding tracker — rounds as reported by the linked publications.
This profile was compiled from Future Fertility's own public pages in July 2026 and reflects what the company states about itself — not an endorsement or an independent audit of those claims. Facts are extracted with AI and filtered by an automated check that drops any named product, customer or certification missing from the source pages. Full method. Something out of date? Tell us.